Results of long-term survival analysis of the phase III EMPOWER-Cervical 1 multicenter clinical trial show that immune checkpoint inhibitor cemiplimab…
featured news
Published in the flagship journal of the European Society for Medical Oncology, Annals of Oncology, renowned leaders in the field…
Published in Molecular Cancer Therapeutics*, a journal of the American Association for Cancer Research (AACR), results of a study co-led…
Founded by Cancer Research UK (CRUK) and the National Cancer Institute (NIH-NCI, USA) the Cancer Grand Challenges are internationally funded…
Results of a VHIO co-led retrospective study published in JCO Precision Oncology verify the use of diagnostic archival tissue biopsies…
Many of our Medical Oncologists and Clinical Investigators have just returned from presenting their latest data at the European Society…
The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…
The 12th Annual two-day WIN Symposium 2022, co-chaired by Richard L. Schilsky and our Director, Josep Tabernero, Chairman and Vice-Chairman…
The “J-BID – José Baselga Innovative Disruption Program” has an investment of up to 6 million euros and aims to…
For the first time in the context of brain metastasis, VHIO-led research has evidenced the striking preclinical efficacy of a…
